Ra Medical's Kraws expects Pharos to continue momentum
Ra Medical (RMED) develops and commercializes excimer lasers as tools for the treatment of vascular and dermatological diseases. In an exclusive interview with The Fly, the company's President Jeffrey Kraws discusses Ra Medical's dermatology business: "We gave a preliminary range for the [second] quarter and it was a preliminary range for vascular and a preliminary range for dermatology as we have not published the results yet. However, we are putting the necessary resources behind each of our business segments to help them perform as well as possible. Our dermatology segment is receiving a very positive response from our recently launched Pharos optimize system, which we hope will continue to be well received in the marketplace." "Meet the Company" is The Fly's recurring series of exclusive short interviews with Executive Officers to offer a deeper look inside the company. The remainder of this interview to follow.